Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-05-23
2006-05-23
Wilson, James O. (Department: 1623)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S025300, C536S025340, C536S025600
Reexamination Certificate
active
07049432
ABSTRACT:
The present invention provides alkylphosphonate dimers and oligonucleotides prepared therefrom. The invention further provides novel methods for the preparation of these alkylphosphonate dimers. Methods for the preparation of substantially diastereomerically pure alkylphosphonate dimers are also provided.
REFERENCES:
patent: 3687808 (1972-08-01), Merigan et al.
patent: 5210264 (1993-05-01), Yau
patent: 5670633 (1997-09-01), Cook et al.
patent: 6486313 (2002-11-01), Manoharan et al.
patent: WO 94/00472 (1994-01-01), None
patent: WO 94/00473 (1994-01-01), None
Wang et al., J. Org. Chem. 1999, 64, 2595-2598.
Agrawal et al. (eds.), “Methods of Molecular Biology”, inProtocols for Oligonucleotide Conjugates,Agrawal, S. (ed.), Humana Press, New Jersey, 1994, vol. 26, 1-72.
Beaucage, S.L. et al., “Advances in the Synthesis of Oligonucleotides by the Phosphoramidite Approach”,Tetrahedron,1992, 48, 2223-2311.
Cook, P.D., “Medicinal Chemistry of Antisense Oligonucleotides—future opportunities”,Anti-Cancer Drug Design,1991, 6, 585-607.
Delgado, C. et al., “The Uses and Properties of PEG-Linked Proteins”,Crit. Rev. in Therapeutic Drug Carrier Sys.,1992, 9, 249-304.
Eisenhardt et al., “Backbone Modified Antisense Oligodeoxy-Nucleotides Directed Against the Hepatitis-C-Virus (HCV)-RNA”,Nucleosides&Nucleotides,1997, 16(7-9), 1669-1672.
Englisch, U. et al., “Chemically Modified Oligonucleotides as Probes and Inhibitors”,Angew. Chem. Int. Ed. Eng.,1991, 30, 613-629.
Hamm et al., Incorporation of 2′-Deoxy-2′-mercaptocytidine into Oligonucleotides via Phosphoramidite Chemistry,J. Org. Chem.,1997, 62, 3415-3420.
Jaworska-Maslanka et al., “Studies on Stereospecific Formation of P-Chiral Internucleotide Linkage: Synthesis of all-Rp and all-Sp Methylphosphonate Pentanucleotide d(MMTrAPMeTPMeTPMeCPMeTAc) via Grignard Activated Coupling”,Antisense&Nucl. Acid Drug Devel.,1997, 7, 23-30.
Kroschwitz, J.I., “Polynucleotides”,Concise Encyclopedia of Polymer Science and Engineering,1990, John Wiley & Sons, New York, 858-859.
Larock, R.C.,Comprehensive Organic Transformations: A Guide To Functional Group Preparations,VCH, New York, 1989, 411-415.
Miller et al., “Anticode Oligonucleoside Methylphosphonates and Their Psoralen Derivatives”,Antisense Research and Applications,Crooke, S.T. et al. (eds.), CRC Press, Boca Raton, 1993, Ch. 10, 189-203.
Ouchi, T. et al., “Synthesis and Antitumor Activity of Poly(Ethylene Glycol)s Linked to 5′-Fluorouracil via a Urethane or Urea Bond”,Drug Des.&Disc.,1992, 9, 93-105.
Polushin et al., “Synthesis of Oligonucleotides Containing 2′-Azido- and 2′-Amino-2′- deoxyuridine Using Phosphotriester Chemistry”,Tetrahedron Lett.,1996, 37(19), 3227-3230.
Ravasio, N. et al., “Selective Hydrogenations Promoted by Copper Catalysts. 1. Chemoselectivity, Regioselectivity, and Stereoselectivity in the Hydrogenation of 3- Substituted Steroids”,J. Org. Chem.,1991, 56, 4329-4333.
Seela, F. et al., “Diastereomerically Pure RPand SPDinucleoside H-Phosphonates: The Stereochemical Course of Their Conversion into P-Methylphosphonates, Phosphorothioates, and [18O] Chiral Phosphates”,J. Org. Chem.,1991, 56, 3861-3869.
Thomson J. et al., “Synthesis and Properties of Diuridine Phosphate Analogues Containing Thio and Amino Modifications”,J. Org. Chem.,1996, 61, 6273-6281.
Wang, J.C. et al., “A Stereoselective Synthesis of Dinucleotide Phosphorothioates, Using Chiral Indol-oxazaphosphorine Intermediates”,Tetrahedron Lett.,1997, 38(22), 3797-3800.
Agrawal, S. (ed.), inProtocols For Oligonucleotides And Analogs,Humana Press, Totowa, NJ, 1993.
Green and Wuts, inProtective Groups in Organic Synthesis,2d edition, John Wiley & Sons, New York, 1991.
Just, et al., A Stereoselective Synthesis of Dinuclotide Boranophosphate, Using Chiral Indole-oxazaphosphorine Intermediates.Tetrahedron Letters,1998, 39, 6433-6436.
Guzaev, et al., “A Novel support for Synthesis of 3′-Phosphorylated Chimeric Oligonucleotides Containing Internucleosidic Methyl Phosphotriester and Methylphosphonate Linkages”,Tetrahedron Letters ,1997, 38, No 22, 3989-3992.
Just, et al., The Synthesis of the Sp and Rp Diastereomers of Dithymidine Boranophosphate,Tetrahedron Letters,1998, 39, 6429-6432.
Jin, Y. et al., “A Stereoselective Synthesis of Dinucleotide Boranophosphate, Using Chiral Indole-oxazaphosphorine Intermediates”,Tetrahedron Letters,1998, 39, 6433-6436.
Fathi, R., et al., “Oligonucleotide with novel, cationic backbone substituents: antioethylphosphonates,”Nucleic Acid Res., 1994,22(24), 5416-5424.
U.S. patent application Ser. No. 08/398,901, Cook et al., filed Mar. 6, 1995.
U.S. patent application Ser. No. 09/123,108, Manoharan et al., filed Jul. 27, 1998.
U.S. patent application Ser. No. 09/130,973, Manoharan et al., filed Aug. 7, 1998.
Guzaev Andrei
Jung Michael E.
Just George
Manoharan Muthiah
Roland Arlène
ISIS Paten Department
ISIS Pharmaceuticals Inc.
McGill University
Owens, Jr. Howard V.
Wilson James O.
LandOfFree
Oligonucleotides having alkylphosphonate linkages and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligonucleotides having alkylphosphonate linkages and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotides having alkylphosphonate linkages and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3594072